Gastroenterology

HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules

HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules

Source link

Related posts

Management of IBD during the COVID-19 outbreak: resetting clinical priorities

Newsemia

American Gastroenterological Association Institute Guideline on the Management of Mild-Moderate Ulcerative Colitis

Newsemia

March is Colon Cancer Awareness Month!

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World